title: Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) reduces infection-related mortality after allogeneic T-cell depleted BMT.
authors.affiliation: University Hospital Nijmegen, The Netherlands.
authors.forename: T
authors.initials: T
authors.lastname: De Witte
authors.forename: A
authors.initials: A
authors.lastname: Gratwohl
authors.forename: N
authors.initials: N
authors.lastname: Van der Lely
authors.forename: A
authors.initials: A
authors.lastname: Bacigalupo
authors.forename: A C
authors.initials: AC
authors.lastname: Stern
authors.forename: B
authors.initials: B
authors.lastname: Speck
authors.forename: A
authors.initials: A
authors.lastname: Schattenberg
authors.forename: C
authors.initials: C
authors.lastname: Nissen
authors.forename: E
authors.initials: E
authors.lastname: Gluckman
authors.forename: W E
authors.initials: WE
authors.lastname: Fibbe
mesh_terms: D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D004311:Double-Blind Method; D005060:Europe / Q000453:epidemiology; D006085:Graft Survival / Q000187:drug effects; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D017053:Infection Control; D007239:Infections / Q000209:etiology / Q000401:mortality; D007958:Leukocyte Count / Q000187:drug effects; D008212:Lymphocyte Depletion; D009503:Neutropenia / Q000150:complications / Q000628:therapy; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D007155:Immunologic Factors; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor